Your browser doesn't support javascript.
loading
Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma.
Tan, Qin; Zhang, Chaoting; Yang, Wenjun; Liu, Ying; Heyilimu, Palashati; Feng, Dongdong; Xing, Liying; Ke, Yang; Lu, Zheming.
Afiliação
  • Tan Q; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Genetics, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing, 100142, China.
  • Zhang C; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing, 100142, China. chaotingzhang@bjmu.edu.cn.
  • Yang W; Key Laboratory of Fertility Preservation and Maintenance (Ministry of Education), Cancer Institute of the General Hospital, Ningxia Medical University, Yinchuan, Ningxia, 750004, People's Republic of China.
  • Liu Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Genetics, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing, 100142, China.
  • Heyilimu P; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing, 100142, China.
  • Feng D; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Head and Neck Surgery, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing, 100142, China.
  • Xing L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing, 100142, China.
  • Ke Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Genetics, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing, 100142, China. keyang@bjmu.edu.cn.
  • Lu Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing, 100142, China. luzheming@bjmu.edu.cn.
J Immunother Cancer ; 7(1): 232, 2019 08 28.
Article em En | MEDLINE | ID: mdl-31462302
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Receptores de Antígenos de Linfócitos T / Linfócitos T / Linfócitos do Interstício Tumoral / Citotoxicidade Imunológica / Carcinoma de Células Escamosas do Esôfago Limite: Animals / Female / Humans / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Receptores de Antígenos de Linfócitos T / Linfócitos T / Linfócitos do Interstício Tumoral / Citotoxicidade Imunológica / Carcinoma de Células Escamosas do Esôfago Limite: Animals / Female / Humans / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido